Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Thoracic 1Lymphoid 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Sarcoma 43Melanoma 19Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Neoplasm Metastasis 11Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 9Glioblastoma 8Colorectal Neoplasms 8Triple Negative Breast Neoplasms 7Pancreatic Neoplasms 7Ovarian Neoplasms 7Gliosarcoma 7Lung Neoplasms 6Histiocytoma, Malignant Fibrous 6Carcinoma, Renal Cell 6Osteosarcoma 5Liposarcoma 5Head and Neck Neoplasms 5Carcinoma, Hepatocellular 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Sarcoma, Synovial 4Sarcoma, Kaposi 4Neurofibrosarcoma 4Lymphoma 4Leiomyosarcoma 4Hemangiosarcoma 4Carcinoma, Merkel Cell 4Urinary Bladder Neoplasms 3

Interventions

Cyclophosphamide 13fludarabine 7Trabectedin 4Radiation Dose Hypofractionation 3seclidemstat 2pembrolizumab 2Topotecan 2Interferon-gamma 2selinexor 1ribociclib 1pazopanib 1palbociclib 1mirdametinib 1itacitinib 1interferon gamma-1b 1fludarabine phosphate 1cytochrome C synthetase 1brostallicin 1baricitinib 1atezolizumab 1aldesleukin 1X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1Sirolimus 1Radiotherapy 1Radiation 1Proton Therapy 1Pioglitazone 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Liposarcoma, Myxoid × pembrolizumab × Sarcoma × Clear all
NCT05492682 2026-05-12

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Valo Therapeutics Oy

Phase 1 Recruiting
15 enrolled
BreastDermatologicGastrointestinalSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Sarcoma, Osteosarcoma, Sarcoma, Synovial, Colorectal Neoplasms, Liposarcoma, Myxoid, Triple Negative Breast Neoplasms

NCT03063632 2023-10-25

Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
28 enrolled 15 charts
LymphoidSarcoma

Mycosis Fungoides, Sezary Syndrome, Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡